In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity

In situ tumor vaccine is a potential cancer therapy due to their advantages in induction of antitumor immune responses. Oncolytic virotherapy utilizes natural or engineered oncolytic viruses to kill tumors selectively, representing a promising in situ tumor vaccine for cancer immunotherapy. In addit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bin, Shu, Yongheng, Hu, Shichuan, Qi, Zhongbing, Chen, Yanwei, Ma, Jinhu, Wang, Yunmeng, Cheng, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273963/
https://www.ncbi.nlm.nih.gov/pubmed/35837100
http://dx.doi.org/10.3389/fonc.2022.897561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273963/
https://www.ncbi.nlm.nih.gov/pubmed/35837100
http://dx.doi.org/10.3389/fonc.2022.897561

Ejemplares similares